Filter Results:
(4,840)
Show Results For
- All HBS Web
(4,840)
- People (17)
- News (1,878)
- Research (2,381)
- Events (2)
- Multimedia (212)
- Faculty Publications (1,875)
Show Results For
- All HBS Web
(4,840)
- People (17)
- News (1,878)
- Research (2,381)
- Events (2)
- Multimedia (212)
- Faculty Publications (1,875)
- 23 Jun 2023
- HBS Case
This Company Lets Employees Take Charge—Even with Life and Death Decisions
care teams after experiencing firsthand as a nurse, and then a decade as a senior leader of two large health care organizations, how the health... View Details
- 17 Jun 2019
- Research & Ideas
What Hospitals Must Learn to Compete
Harvard Business School professors Raffaella Sadun and Leemore Dafny are both economists who have studied hospitals extensively—Sadun’s research has looked at the economics of management, while Dafny’s examines interactions between health... View Details
- 27 Sep 2011
- First Look
First Look: September 27
the salience of information is a central determinant of a firm's demand function, even for purchases as large as college attendance. Download the paper: http://www.hbs.edu/research/pdf/12-014.pdf Measuring Teamwork in Health View Details
Keywords: Sean Silverthorne
- September 2013 (Revised January 2016)
- Case
The Abraaj Group and the Acibadem Healthcare Investment (A)
By: Paul A. Gompers, Bora Uluduz and Firdevs Abacioglu
This case concerns the proposed buyout of Acibadem, a leading hospital chain in Turkey. Abraaj, a MENA region private equity firm, proposes to make its first investment in Turkey. The case highlights the role of Turkish health care reform in driving the value. The... View Details
Gompers, Paul A., Bora Uluduz, and Firdevs Abacioglu. "The Abraaj Group and the Acibadem Healthcare Investment (A)." Harvard Business School Case 214-021, September 2013. (Revised January 2016.)
- July 2020
- Article
Lessons from the Impact of Price Regulation on the Pricing of Anticancer Drugs in Germany
By: Victoria D. Lauenroth, Aaron S. Kesselheim, Ameet Sarpatwari and Ariel Dora Stern
Worldwide spending on prescription drugs has increased dramatically in recent years. Although this increase has been particularly pronounced in the U.S., it remains largely unaddressed there. In Europe, however, different approaches to regulating drug prices have been... View Details
Keywords: Pharmaceuticals; Prescription Drug Costs; Drug Pricing; Access To Care; Cost Reduction; Health Care and Treatment; Price; Governing Rules, Regulations, and Reforms; Cost Management; Germany
Lauenroth, Victoria D., Aaron S. Kesselheim, Ameet Sarpatwari, and Ariel Dora Stern. "Lessons from the Impact of Price Regulation on the Pricing of Anticancer Drugs in Germany." Health Affairs 39, no. 7 (July 2020): 1185–1193.
Robert S. Huckman
Robert Huckman is the Albert J. Weatherhead III Professor of Business Administration at Harvard Business School, the Howard Cox Faculty Chair of the HBS Healthcare Initiative, and the Unit Head for
- 07 Dec 2020
- News
Lifting The Stigma
was amazing. On the outside, I kept racking up awards. And it hit me. I realized how dangerous the stigma of mental health troubles was.” Delle’s response was a 2017 TED talk, “There’s No Shame in Taking View Details
- 01 May 2020
- News
The Business of Medicine in the Era of COVID-19
- February 2015
- Article
The Great Recession, Insurance Mandates, and the Use of In Vitro Fertilization Services in the United States
By: Sorapop Kiatpongsan, Robert S. Huckman and Mark D. Hornstein
Objective: To investigate the relationship between economic activities, insurance mandates, and the use of in vitro fertilization (IVF) in the United States.
Design: We examined the correlation between the coincident index (a proxy for overall economic... View Details
Design: We examined the correlation between the coincident index (a proxy for overall economic... View Details
Keywords: Macroeconomics; Recessions; Medical Care; In Vitro Fertilization; Health Industry; United States
Kiatpongsan, Sorapop, Robert S. Huckman, and Mark D. Hornstein. "The Great Recession, Insurance Mandates, and the Use of In Vitro Fertilization Services in the United States." Fertility and Sterility 103, no. 2 (February 2015): 448–454.
- 20 Nov 2015
- News
Cowboy Doctors Are Rustling Up Healthcare Costs
- January 2019 (Revised February 2024)
- Teaching Note
Hubble Contact Lenses: Data Driven Direct-to-Consumer Marketing
By: Ayelet Israeli
Teaching Note for HBS No. 519-011. As its Series A extension round approaches, the founders of Hubble, a subscription-based, social-media fueled, direct-to-consumer (DTC) brand of contact lenses, are reflecting on the marketing strategies that have taken them to a... View Details
Keywords: DTC; Direct To Consumer Marketing; Health Care; Mobile; Attribution; Experimentation; Experiments; Churn/retention; Customer Lifetime Value; Internet Marketing; Big Data; Analytics; A/B Testing; CRM; Advertising; Marketing; Marketing Channels; Marketing Strategy; Media; Brands and Branding; Marketing Communications; Digital Marketing; Acquisition; Growth and Development Strategy; Customer Focus and Relationships; Consumer Behavior; Social Media; E-commerce
- July 2014 (Revised November 2017)
- Course Overview Note
Entrepreneurship in Healthcare IT and Services (EHITS) Spring Term 2018: Course Outline and Syllabus
By: Robert F. Higgins
This is the syllabus and course outline for "Entrepreneurship in Healthcare IT and Services (EHITS)" taught by Prof. Bob Higgins in the spring of 2018. Contains the course overview, objectives, goals and themes. View Details
Keywords: Healthcare Technology; Health Services; Healthcare Ventures; Entrepreneurship; Health Care and Treatment; Information Technology; Health Industry; Health Industry; United States
Higgins, Robert F. "Entrepreneurship in Healthcare IT and Services (EHITS) Spring Term 2018: Course Outline and Syllabus." Harvard Business School Course Overview Note 815-005, July 2014. (Revised November 2017.)
- August 2013 (Revised September 2013)
- Course Overview Note
Entrepreneurship in Healthcare IT Services (EHITS) Fall Term 2013: Course Outline and Syllabus
By: Robert F. Higgins
This is the syllabus and course outline for "Entrepreneurship in Healthcare IT and Services (EHITS)" taught by Prof. Bob Higgins in the fall of 2013. Contains the course overview, objectives, goals and themes. View Details
Keywords: Healthcare Technology; Health Services; Healthcare Ventures; Entrepreneurship; Health Care and Treatment; Information Technology; Health Industry; Health Industry; United States
Higgins, Robert F. "Entrepreneurship in Healthcare IT Services (EHITS) Fall Term 2013: Course Outline and Syllabus." Harvard Business School Course Overview Note 814-022, August 2013. (Revised September 2013.)
- March 2019
- Case
DayTwo: Going to Market with Gut Microbiome
By: Ayelet Israeli and David Lane
DayTwo is a young Israeli startup that applies research on the gut microbiome and machine learning algorithms to deliver personalized nutritional recommendations to its users in order to minimize blood sugar spikes after meals. After a first year of trial rollout in... View Details
Keywords: Start-up Growth; Startup; Positioning; Targeting; Go To Market Strategy; B2B2C; B2B Vs. B2C; Health ＆ Wellness; AI; Machine Learning; Female Ceo; Female Protagonist; Science-based; Science And Technology Studies; Ecommerce; Applications; DTC; Direct To Consumer Marketing; US Health Care; ＂USA,＂; Innovation; Pricing; Business Growth; Segmentation; Distribution Channels; Growth and Development Strategy; Business Startups; Science-Based Business; Health; Innovation and Invention; Marketing; Information Technology; Business Growth and Maturation; E-commerce; Applications and Software; Health Industry; Health Industry; Health Industry; Health Industry; Health Industry; Israel; United States
Israeli, Ayelet, and David Lane. "DayTwo: Going to Market with Gut Microbiome." Harvard Business School Case 519-010, March 2019.
- 10 Oct 2009
- News
Making the 'public option' a simple one
- 30 Sep 2013
- News
What you may not be hearing about the ACA
- Article
Managing Healthcare Costs and Value
By: Robert S. Kaplan, Michael E. Porter and Mark L. Frigo
Rising health care costs are a major global challenge. A number of factors contribute to this trend, including aging populations and medical technology. But an underlying and misunderstood source of health care’s escalating costs has been the inability of health care... View Details
Kaplan, Robert S., Michael E. Porter, and Mark L. Frigo. "Managing Healthcare Costs and Value." Strategic Finance 98, no. 7 (January 2017): 24–33.
- Article
Time-Driven Activity-Based Costing: A Driver for Provider Engagement in Costing Activities and Redesign Initiatives
By: Robert S. Kaplan, Nancy McLaughlin, Michael A. Burke, Nisheeta P. Setlur, Douglas R. Niedzwiecki, Alan L. Kaplan, Christopher Saigal, Aman Mahajan and Neil A. Martin
Object. To date, health care providers have devoted significant efforts to improve performance regarding patient safety and quality of care. To address the lagging involvement of health care providers in the cost component of the value equation, UCLA Health... View Details
Kaplan, Robert S., Nancy McLaughlin, Michael A. Burke, Nisheeta P. Setlur, Douglas R. Niedzwiecki, Alan L. Kaplan, Christopher Saigal, Aman Mahajan, and Neil A. Martin. "Time-Driven Activity-Based Costing: A Driver for Provider Engagement in Costing Activities and Redesign Initiatives." Neurosurgical Focus 37, no. 5 (November 2014).
- Profile
Luc Sirois
The health care industry needs so much improvement, it will take a whole movement to fix it. “The more leaders, the better,” says Luc Sirois (MBA 1997), who sees progress coming not through a single... View Details